Fulminant Hepatitis B as a Result of Reactivation in Hematologic Patient After Rituximab Therapy

Yilmaz, Bulent2020-03-262020-03-2620160146-66151096-9071https://dx.doi.org/10.1002/jmv.24476https://hdl.handle.net/20.500.12395/33631[Abstract not Available]en10.1002/jmv.24476info:eu-repo/semantics/closedAccessFulminant Hepatitis B as a Result of Reactivation in Hematologic Patient After Rituximab TherapyLetter8881289129027249067Q1WOS:000383669500001Q3